Rezolute RZLT
NASDAQ RZLT
$4.58 +0.04 (+0.88%)
As of: Sep 4, 2026 · 3:59 PM EDT

Rezolute (RZLT) Accumulated Depreciation (2018 - 2025)

Rezolute (RZLT) posted Accumulated Depreciation of $138000.0 for Q2 2025, up 28.97% sequentially from $107000.0 in Q2 2024, and up 28.97% YoY from $107000.0 in Q2 2024.

Analysis

Rezolute (RZLT) Accumulated Depreciation (2018 - 2025) Analysis & Trends

Rezolute has reported Accumulated Depreciation for 8 years, with the latest figure at $138000.0 in Q2 2025.

  • Quarterly Accumulated Depreciation rose 28.97% year-over-year to $138000.0 in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $138000.0 (up 28.97% YoY) and the FY2025 annual result came in at $138000.0, up 28.97% from the prior year.
  • Accumulated Depreciation improved to $138000.0 in Q2 2025 per RZLT's latest filing, from $107000.0 in the prior quarter.
  • Over five years, Accumulated Depreciation peaked at $138000.0 in Q2 2025 and troughed at $27000.0 in Q2 2021.
  • A 5-year average of $76600.0 and a median of $71000.0 in 2023 frame the typical range for Accumulated Depreciation.
  • The sharpest annual moves came in 2021 and 2025: Accumulated Depreciation jumped 92.86% in 2021, then gained 28.97% in 2025.
  • Over 5 years, Accumulated Depreciation stood at $27000.0 in 2021, then jumped by 48.15% to $40000.0 in 2022, then surged by 77.5% to $71000.0 in 2023, then jumped by 50.7% to $107000.0 in 2024, then gained by 28.97% to $138000.0 in 2025.
  • According to Business Quant data, Accumulated Depreciation over the past three periods registered $138000.0, $107000.0, and $71000.0 for Q2 2025, Q2 2024, and Q2 2023 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Rezolute 477.02 Mn 477.02 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 138,000.00
Jun 30, 2024 107,000.00
Jun 30, 2023 71,000.00
Jun 30, 2022 40,000.00
Jun 30, 2021 27,000.00
Jun 30, 2020 14,000.00
Jun 30, 2019 3,000.00
Jun 30, 2018 518,000.00